CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,256 | -50.5% | 536,999 | -29.2% | 0.00% | -50.0% |
| Q4 2022 | $4,557 | -99.9% | 758,361 | +11.8% | 0.00% | -50.0% |
| Q3 2022 | $3,950,000 | +14007.1% | 678,613 | +14450.0% | 0.00% | – |
| Q2 2022 | $28,000 | – | 4,664 | +29050.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 16 | -98.4% | 0.00% | – |
| Q4 2021 | $2,000 | -97.4% | 1,032 | -96.0% | 0.00% | – |
| Q3 2021 | $77,000 | +450.0% | 26,108 | +365.8% | 0.00% | – |
| Q2 2021 | $14,000 | -92.6% | 5,605 | -91.4% | 0.00% | – |
| Q1 2021 | $190,000 | +9400.0% | 64,954 | +12463.6% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 517 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 517 | -63.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 1,397 | +170.2% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 517 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 517 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 517 | -48.7% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 1,007 | -93.3% | 0.00% | – |
| Q1 2019 | $15,000 | – | 14,955 | +2792.6% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 517 | -97.8% | 0.00% | – |
| Q3 2018 | $51,000 | -73.6% | 23,764 | -38.5% | 0.00% | – |
| Q2 2018 | $193,000 | +0.5% | 38,670 | -21.6% | 0.00% | – |
| Q1 2018 | $192,000 | +19100.0% | 49,324 | +9349.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 522 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 522 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 522 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
| FNY Investment Advisers, LLC | 20 | $0 | 0.00% |